⌘K

Home/Filings/4/0001209191-22-021619

4//SEC Filing

Harsh Michael 4

Accession 0001209191-22-021619

CIK 0001681682other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 5:15 PM ET

Size

5.3 KB

Accession

0001209191-22-021619

Insider Transaction Report

Form 4

Period: 2022-03-28

ENDRA Life Sciences Inc.NDRA

Director

Transactions

Award
Stock Options
2022-03-28+109,492→ 109,492 total
Exercise: $0.38Exp: 2032-03-28→ Common Stock (109,492 underlying)

Footnotes (1)

[F1]This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1

filerCIK 0001706155

Filing Metadata

Form type: 4
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 5:15 PM ET
Size: 5.3 KB

View on SEC.gov